UAB / UMN SPORE in Pancreatic Cancer
UAB / UMN SPORE in Pancreatic Cancer
批准号:
8277122
负责人:
DONALD J. BUCHSBAUM
金额:
$230.0万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-16 至 2015-06-30
关键词:
Adenovirus VectorAdvisory CommitteesAdvocacyAdvocateAgreementAnimal ModelBioinformaticsBiological MarkersBiologyBiometryBiopsyBiostatistics CoreBrainBreastCancer BiologyCancer PatientCancer cell lineCantorCell LineCell physiologyCellular biologyChairpersonCitiesClinicClinicalClinical DataClinical InvestigatorClinical ManagementClinical ResearchClinical ServicesClinical TrialsCollaborationsCollectionCommunicationComprehensive Cancer CenterCritiquesDataData AnalysesData CollectionDevelopmentDiagnosisDiseaseDoctor of MedicineDoctor of PhilosophyDuctal Epithelial CellEngineeringEnrollmentEnsureErbituxEvaluationEventExternal Beam Radiation TherapyFacultyFine needle aspiration biopsyFundingFutureGene Expression ProfilingGenesGeneticGenomicsGrantGroup MeetingsGuidelinesHeadHeat shock proteinsHematologyHospitalsHumanHuman GeneticsImageImmunologyInstitutionInterdisciplinary StudyInterviewJointsLaboratoriesLeadLeadershipMagnetic Resonance ImagingMalignant NeoplasmsMalignant neoplasm of pancreasMedical centerMedicineMethodologyMethodsMinnesotaModelingMolecularMolecular MedicineMonoclonal AntibodiesMorehouse School of MedicineMusMutationNeoplasm MetastasisNewly DiagnosedOperative Surgical ProceduresPancreasParaffin EmbeddingParticipantPathologyPathway interactionsPatient advocacyPatientsPatternPersonal BehaviorPersonsPhase I Clinical TrialsPhase II Clinical TrialsPhenotypePilot ProjectsPoliciesPopulationPreparationPreventive MedicinePrincipal InvestigatorProblem SolvingProceduresProcessProductivityProteomicsProtocols documentationPublic Health SchoolsPublicationsQuality ControlRadiation OncologyRecommendationReportingResearchResearch ActivityResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingResistanceResource AllocationReverse Transcriptase Polymerase Chain ReactionRoleSamplingSchoolsScienceScientific EvaluationScientistSerumSiteStagingStudy SectionSurgeonSurgical OncologyTNFRSF10B geneTechniquesTechnologyTeleconferencesTherapeuticTherapeutic StudiesTimeTissue BanksTissuesTransgenic AnimalsTransgenic MiceTransgenic OrganismsTranslational ResearchTranslationsTransplantationTreatment EfficacyTwin Multiple BirthUnited States National Institutes of HealthUniversitiesUniversity of Minnesota Cancer CenterUniversity of Texas M D Anderson Cancer CenterUrineVideoconferencesVideoconferencingVirginiaVisitWalkersWood materialWorkbasebench to bedsidecancer educationcancer research center directorcancer stem cellcareer developmentcellular pathologydata managementdensitydesignexperiencegemcitabineimmunopathologyinformatics shared resourcemalignant breast neoplasmmedical schoolsmeetingsmembermolecular pathologymouse modelneoplastic cellnoveloncologypancreatic cancer cellsprofessorprognostic indicatorprogramsresearch and developmentresponsesample collectionstandard of carestatistical servicetissue resourcetumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Six years ago, our UAB SPORE in Pancreatic Cancer application was partially funded via a P-20 grant. With limited funding; our mini-SPORE was composed of 2 major projects, 3 Cores and a Developmental Research Program. During this initial funding period, translation of SPORE science resulted in two phase I trials, one Phase II trial and a novel MRI imaging trial. The investigators of the SPORE have 88 publications relating to SPORE projects or pancreatic cancer. The Developmental Research funding resulted in two major projects, Projects 1, & 4 in this renewal application and 2 awardees becoming Project co-leaders. Three years ago, Dr. Vickers (SPORE PI) became Chairman of Surgery at the University of Minnesota (UMN) and we restructured into a joint UAB/UMN SPORE in Pancreatic Cancer. The joint SPORE has functioned well and this proposal is our amended competitive renewal for full SPORE funding (PSO application). This proposal has 4 major projects: Project 1 is utilizing proteomic techniques in transgenic animal models to identify biomarkers that are predictive of early stage pancreatic cancer; Project 2 is a continuation project which is examining multiple methods to enhance the therapeutic efficacy of anti-DR5 monoclonal antibodies in pancreatic cancer animal models and patients; Project 3 is utilizing genomic and genetic data obtained from human pancreatic cancer (PCa) samples and observations from mouse models of PCa to understand the genetic events that drive metastasis and treatment resistance in this disease. These studies will lead to a phase I clinical trial; Project 4 is engineering novel conditionally replicative adenoviral vectors that target pancreatic cancer stem cell-like tumor cells for the treatment of metastatic pancreatic cancer. The four important and effective Cores are: 1) Administration; 2) Tissue Resource and Molecular Pathology; 3) Biostatistics; and 4) Clinical Management and Trials (Advocacy Sub-Core). We also request support for continuation of our Developmental Research and Career Development Programs which includes Morehouse School of Medicine and Tuskegee University. The application has strong institutional support from UAB and UMN, excellent pancreatic cancer populations and concurrence with federal guidelines.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Therapy of pancreatic cancer with 212Pb-labeled B7-H3 specific Ab and LDE225
-
批准号:8637541
-
项目类别:
-
资助金额:$18.6万
-
财政年份:2014
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
Career Development Program
-
批准号:7962166
-
项目类别:
-
资助金额:$21.76万
-
财政年份:2010
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
Administrative Core
-
批准号:7962142
-
项目类别:
-
资助金额:$12.64万
-
财政年份:2010
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
Developmental Research Program
-
批准号:7962164
-
项目类别:
-
资助金额:$8.57万
-
财政年份:2010
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
Combined Modality Targeted Therapy of Pancreatic Cancer with Death Receptor
-
批准号:7962128
-
项目类别:
-
资助金额:$18.36万
-
财政年份:2010
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
UAB / UMN SPORE in Pancreatic Cancer
-
批准号:8131055
-
项目类别:
-
资助金额:$218.5万
-
财政年份:2003
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
UAB / UMN SPORE in Pancreatic Cancer
-
批准号:8528346
-
项目类别:
-
资助金额:$215.05万
-
财政年份:2003
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
SPORE in Pancreatic Cancer
-
批准号:7287817
-
项目类别:
-
资助金额:$85.56万
-
财政年份:2003
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
UAB / UMN SPORE in Pancreatic Cancer
-
批准号:8707193
-
项目类别:
-
资助金额:$216.2万
-
财政年份:2003
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
UAB / UMN SPORE in Pancreatic Cancer
-
批准号:7939097
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2003
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
SPORE in Pancreatic Cancer
-
批准号:7090644
-
项目类别:
-
资助金额:$88.11万
-
财政年份:2003
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
EVALUATION OF CH2 DELETED HUCC49 FOR INTRAPERITONEAL RIT
-
批准号:6376847
-
项目类别:
-
资助金额:$22.68万
-
财政年份:1999
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
EVALUATION OF CH2 DELETED HUCC49 FOR INTRAPERITONEAL RIT
-
批准号:2856503
-
项目类别:
-
资助金额:$22.74万
-
财政年份:1999
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
EVALUATION OF CH2 DELETED HUCC49 FOR INTRAPERITONEAL RIT
-
批准号:6174021
-
项目类别:
-
资助金额:$22.18万
-
财政年份:1999
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
GENETIC RADIOIMMUNOTHERAPY OF PANCREATIC CANCER
-
批准号:6137597
-
项目类别:
-
资助金额:$21.22万
-
财政年份:1998
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
GENETIC RADIOIMMUNOTHERAPY OF PANCREATIC CANCER
-
批准号:2856453
-
项目类别:
-
资助金额:$20.69万
-
财政年份:1998
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
GENETIC RADIOIMMUNOTHERAPY OF PANCREATIC CANCER
-
批准号:2488567
-
项目类别:
-
资助金额:$20.17万
-
财政年份:1998
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
01 Inflammation, Immunology and Immunotherapeutics Program
-
批准号:10362795
-
项目类别:
-
资助金额:$2.66万
-
财政年份:1997
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
NEW BCAS FOR RADIOIMMUNOTHERAPY WITH RADIOMETALS
-
批准号:6376044
-
项目类别:
-
资助金额:$25.91万
-
财政年份:1996
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
NEW BCAS FOR RADIOIMMUNOTHERAPY WITH RADIOMETALS
-
批准号:2909189
-
项目类别:
-
资助金额:$25.79万
-
财政年份:1996
-
负责人:DONALD J. BUCHSBAUM
-
依托单位:
海外基金